Work

Adalimumab in Japanese patients with moderate to severe chronic plaque psoriasis: Efficacy and safety results from a Phase II/III randomized controlled study

Year: 2010

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: The Journal of Dermatology

DOI: 10.1111/j.1346-8138.2009.00748.x

Authors: Akihiko ASAHINA, Hidemi NAKAGAWA, Takafumi ETOH, Mamitaro OHTSUKI, THE ADALIMUMAB M04‐688 STUDY GROUP

Institutions: National Sagamihara Hospital, Jikei University School of Medicine, Tokyo Teishin Hospital, Jichi Medical University

Language: English

Topic: Psoriasis: Treatment and Pathogenesis

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Abbott Japan

OpenAlex ID: W2005176759

FWCI: 5.398

Cites: 16

Cited by: 185

Related to: 10